<DOC>
<DOCNO>
EP-0013789
</DOCNO>
<TEXT>
<DATE>
19800806
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-231/56</main> C07D-231/00 C07D-231/56 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
amino-substituted 4,5,6,7-tetrahydro-1h (or 2h)-indazoles, their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
lilly co elius  <sep>eli lilly and company<sep>eli lilly and company307, east mccarty streetindianapolis indiana 46285us<sep>eli lilly and company  <sep>
</APPLICANT>
<INVENTOR>
bach nicholas james<sep>kornfeld edmund carl<sep>bach, nicholas james<sep>kornfeld, edmund carl<sep>bach, nicholas james4269 burkhart street, e. driveindianapolis, indianaus<sep>kornfeld, edmund carl5159 east 76th courtindianapolis, indianaus<sep>bach, nicholas james<sep>kornfeld, edmund carl<sep>bach, nicholas james4269 burkhart street, e. driveindianapolis, indianaus<sep>kornfeld, edmund carl5159 east 76th courtindianapolis, indianaus<sep>
</INVENTOR>
<ABSTRACT>
novel amino-substituted -4,5,6,7-tetrahydro-1h-(or 2h)-足 indazoles, useful as prolactin inhibitors and in treatment of  parkinson's syndrome, are described herein.  these com足 pounds are prepared by reacting, by reductive alkylation  with an aldehyde or by reacting with an alkyl halide or an足 hydride followed by reduction, an 5(or 6)-amino-4,5,6,7-te足 tetrahydro-1h(or 2h)-indazole compound.  
</ABSTRACT>
</TEXT>
</DOC>
